7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2016-09-30 2016-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 
      
                                                         
      cash flows from operating activities:
                                                         
      net income
    3,874,000 2,054,000 -9,880,000 23,471,000 8,481,000 -642,000 -8,260,000 19,805,000 9,660,000 -1,665,000 -6,296,000 13,725,000 4,789,000 -2,359,000 7,894,000 5,263,000 1,071,000 1,069,000 6,866,000 3,453,000 5,387,000 16,926,000 621,000 -609,000 5,149,000 3,719,000 2,654,000 2,418,000 4,658,000 15,743,000 -726,000 14,439,000 -579,000 3,000,000 -4,510,000 -2,184,000 -1,826,000 439,000 -4,683,000 -10,021,000 -11,326,000 -3,338,000 -1,758,000 496,000 -3,850,000 -322,000 68,000 1,653,000 550,000 -71,000 1,554,000 5,264,000 623,000 
      adjustments to reconcile net income to cash from operating activities
                                                         
      stock-based compensation
    2,207,000 1,936,000 1,963,000 1,810,000 2,412,000 2,817,000 3,283,000 2,227,000 1,791,000 1,718,000 2,302,000 1,407,000 1,497,000 1,724,000 1,880,000 1,479,000 1,233,000 1,428,000 1,913,000 1,115,000 1,077,000 1,092,000 1,503,000 1,251,000 1,354,000 1,393,000 1,678,000 1,014,000 1,042,000 942,000 2,242,000 1,447,000 775,000              597,000 594,000 904,000 716,000 195,000 358,000 356,000 
      depreciation and amortization
    913,000 944,000 962,000 996,000 1,009,000 1,012,000 1,029,000 1,027,000 1,056,000 1,036,000 983,000 -182,000 1,297,000 2,261,000 1,388,000 1,798,000 1,408,000 1,386,000 1,347,000 1,336,000 1,212,000 1,493,000 1,258,000 955,000 1,488,000 1,052,000 900,000 971,000 858,000 916,000 1,124,000 895,000 920,000 940,000 911,000 857,000 969,000 976,000 1,000,000 1,183,000 1,201,000 1,203,000 1,204,000 1,419,000 1,519,000 1,140,000 1,126,000 557,000 234,000 214,000 178,000 144,000 140,000 
      right of use asset amortization
    498,000 472,000 464,000 457,000 447,000 439,000 431,000                                               
      accretion (amortization) of discounts (premiums) on investments
    42,000 -119,000 -231,000 -282,000 -453,000 -365,000 -231,000                                               
      deferred income taxes
    630,000 304,000 -1,641,000 2,025,000 412,000 211,000 -1,328,000 859,000 489,000 -257,000 -1,152,000 951,000 334,000 -478,000 351,000 672,000 378,000 -772,000 -669,000 424,000 777,000 4,701,000 -35,000 223,000 -87,000 736,000 549,000 -235,000 1,362,000 -11,136,000 -376,000 -8,595,000 -71,000 -255,000 56,000 -12,000 44,000 59,000 59,000 -10,000              
      impairment of long-lived assets
    353,000                                                 
      inventory reserve adjustment
                                                         
      other non-cash adjustments
    -326,000 214,000 21,000 -224,000 19,000 172,000 116,000 785,000 92,000 56,000 93,000 -436,000 326,000 -148,000 57,000 794,000 12,000 161,000 -12,000   8,000 47,000    31,000   -1,000 3,000 -76,000 -71,000 -20,000 -29,000 68,000 -20,000 67,000 -2,000 6,000 43,000 -31,000 -25,000 -61,000 -26,000 -25,000       
      changes in operating assets and liabilities:
                                                         
      accounts receivable
    -11,533,000 -198,000 31,677,000 -32,272,000 -11,175,000 4,353,000 21,882,000 -23,629,000 -7,976,000 -3,777,000 22,509,000 -15,688,000 -4,496,000 12,746,000 -6,042,000 -7,549,000 -5,467,000 8,798,000 -4,605,000 -764,000 1,761,000 1,003,000 -902,000 7,938,000 -5,631,000 2,176,000 -7,162,000 -2,546,000 3,630,000 1,130,000 -297,000 -4,091,000 -3,000 1,907,000 1,426,000 -3,105,000 -870,000 -2,976,000 172,000 -2,895,000 4,445,000 67,000 1,325,000 -3,566,000 8,778,000 738,000 -2,844,000 -1,804,000 -1,637,000 3,033,000 9,369,000 -7,515,000 -946,000 
      contract assets
    168,000 -563,000 378,000 -1,302,000 -946,000   -592,000 365,000 762,000 593,000 -829,000 -592,000 493,000 -299,000 -493,000 536,000 1,539,000 -183,000 -453,000 -549,000 46,000 -244,000    2,977,000 -738,000 2,748,000 -1,144,000 1,330,000                       
      inventories
    -1,293,000 -382,000 -7,645,000 8,888,000 194,000 -2,157,000 -5,723,000 7,099,000 2,352,000 -3,242,000 -4,855,000 3,566,000 -3,943,000 -4,782,000 -3,123,000 108,000 -5,253,000 -3,435,000 -186,000 -1,116,000 -766,000 952,000 -692,000 -1,371,000 -1,160,000 -507,000 -218,000 -978,000 13,000 917,000 -1,824,000 -2,089,000 450,000 1,869,000 -1,480,000 549,000 483,000 1,308,000 -508,000 1,158,000 -225,000 -122,000 139,000 2,299,000 60,000 -7,000 -2,858,000 3,959,000 677,000 -1,092,000 -1,661,000 1,289,000 -2,695,000 
      prepaid and other assets
    -356,000 -670,000 -37,000 1,403,000 -1,591,000 -23,000 -545,000 1,196,000 -1,025,000 -454,000 187,000 599,000 -130,000 390,000 -721,000 1,411,000 -1,050,000 -328,000 281,000 120,000 573,000 150,000 -428,000 -646,000 -643,000 1,166,000 -140,000 -237,000 10,032,000 -10,350,000 -127,000 559,000 -214,000 -263,000 -121,000 287,000 -234,000 69,000 570,000 -236,000 1,834,000 -1,917,000 -164,000 -172,000 -751,000 -1,199,000 -534,000 771,000 108,000 -917,000 -471,000 2,076,000 709,000 
      accounts payable
    940,000 96,000 176,000 -92,000 -1,399,000 1,138,000 1,140,000 1,586,000 239,000 -116,000 920,000 -983,000 -1,942,000 -1,555,000 4,618,000 -2,894,000 1,502,000 416,000 821,000 -861,000 -629,000 540,000 745,000 -279,000 -108,000 -4,000 18,000 -76,000 -222,000 -509,000 -1,467,000 2,187,000 278,000 -230,000 -117,000 523,000 188,000 -84,000 -44,000 -23,000 -164,000 469,000 -174,000 -193,000 -1,207,000 -32,000 1,292,000 136,000 -1,420,000 27,000 -459,000 180,000 256,000 
      accrued expenses and other liabilities
    330,000 -274,000 -6,712,000 6,504,000 -197,000 1,319,000 -7,589,000 3,614,000 300,000 1,890,000 -7,156,000 3,555,000 860,000 1,134,000 -6,611,000 3,528,000 867,000 1,183,000 -5,182,000 2,725,000 1,451,000 502,000 -4,514,000 664,000 1,678,000 411,000 -3,353,000 1,357,000 -8,802,000 11,624,000 -4,092,000 1,962,000 1,070,000 140,000 -2,808,000 2,038,000 971,000 1,004,000 -1,945,000 1,319,000 -1,166,000 352,000 -291,000 249,000 -1,456,000 26,000 -1,929,000 848,000 367,000 -611,000 -568,000 570,000 -774,000 
      contract liabilities
    200,000 332,000 830,000 -2,427,000 -216,000 -265,000 2,292,000 -369,000 221,000 -197,000 216,000 -893,000 649,000 -564,000 -1,282,000 1,885,000 315,000 -26,000 -408,000 376,000 187,000 -24,237,000 -3,552,000    -3,922,000 -3,816,000 -4,151,000 -3,295,000 -2,354,000                       
      net cash from operating activities
    -3,131,000 4,146,000 10,678,000 8,955,000 -3,003,000 8,073,000 6,497,000 13,782,000 7,749,000 -4,134,000 8,657,000 6,363,000 -1,211,000 9,081,000 -1,602,000 6,232,000 -4,247,000 11,487,000 54,000 6,520,000 10,644,000 5,578,000 -5,872,000 4,765,000 500,000 5,954,000 -5,951,000 -2,184,000 11,419,000 4,663,000 -6,333,000 568,000 1,478,000 4,703,000 -3,854,000 -2,446,000 -125,000 1,879,000 -3,740,000 -3,756,000 779,000 -2,077,000 -3,202,000 -2,168,000 5,369,000 2,984,000 -4,487,000 7,758,000 -3,379,000 3,205,000 5,233,000 172,000 1,507,000 
      cash flows from investing activities:
                                                         
      maturities of marketable securities
    9,025,000 23,901,000 27,224,000 17,085,000 29,038,000 13,851,000 16,534,000 6,250,000 28,755,000 14,700,000 15,250,000 5,649,000 8,686,000 15,000,000 10,421,000 14,333,000 5,825,000 9,151,000 5,710,000 5,200,000 7,181,000 22,091,000 21,195,000 8,060,000 22,047,000 28,394,000 19,599,000 19,055,000 21,575,000 15,015,000 25,623,000 48,106,000   4,250,000 4,855,000 1,250,000 2,706,000 4,305,000               
      purchases of marketable securities
    -5,237,000 -2,874,000 -14,369,000 -10,507,000 -7,210,000 -52,497,000 -20,783,000 -5,606,000 -29,764,000 -35,299,000 -13,886,000 -7,608,000 -6,587,000 -29,377,000 -5,564,000 -31,305,000   -12,855,000 -18,954,000 -19,704,000 -27,351,000 -19,198,000 -25,858,000 -17,217,000 -29,182,000 -13,935,000 -64,729,000 -1,009,000                     
      capital expenditures
    -342,000 -135,000 -191,000 -104,000 -169,000 -201,000 -824,000 -1,388,000    -1,233,000 -563,000 -460,000 -1,976,000 -1,780,000 -2,450,000 -1,822,000 -627,000 -766,000 -1,609,000 -3,030,000 -1,380,000 -1,881,000 -816,000 -3,119,000 -1,566,000 -3,206,000 -493,000 -910,000 -626,000 -6,476,000 -287,000 -229,000 -384,000 -705,000 -626,000 -465,000 -1,014,000 -125,000 -943,000 -559,000 -339,000 -430,000 -2,531,000 -2,367,000 -4,199,000 -3,052,000 -1,700,000 -2,002,000 -933,000 -291,000 -90,000 
      free cash flows
    -3,473,000 4,011,000 10,487,000 8,851,000 -3,172,000 7,872,000 5,673,000 12,394,000    5,130,000 -1,774,000 8,621,000 -3,578,000 4,452,000 -6,697,000 9,665,000 -573,000 5,754,000 9,035,000 2,548,000 -7,252,000 2,884,000 -316,000 2,835,000 -7,517,000 -5,390,000 10,926,000 3,753,000 -6,959,000 -5,908,000 1,191,000 4,474,000 -4,238,000 -3,151,000 -751,000 1,414,000 -4,754,000 -3,881,000 -164,000 -2,636,000 -3,541,000 -2,598,000 2,838,000 617,000 -8,686,000 4,706,000 -5,079,000 1,203,000 4,300,000 -119,000 1,417,000 
      proceeds from sales of fixed assets
    10,000 43,000 3,000 87,000 5,000    368,000                                          
      net cash from investing activities
    3,446,000 20,892,000 12,674,000 6,517,000 21,659,000 -38,844,000 -4,986,000 -739,000 -1,339,000 -18,203,000 1,167,000 -2,824,000 8,857,000 7,953,000 -20,932,000 6,984,000 -27,930,000 -4,705,000 5,088,000 4,434,000 6,378,000 23,854,000 11,934,000 -8,702,000 5,062,000 -2,076,000 -1,165,000 -10,009,000 3,865,000 -15,077,000 11,062,000 -21,546,000 4,000 -16,292,000 461,000 757,000 -411,000 4,452,000 1,865,000 -23,100,000 -5,677,000 -77,000 582,000 653,000    -21,991,000 -1,488,000 1,297,000 -9,712,000 -560,000 -90,000 
      cash flows from financing activities:
                                                         
      net proceeds from issuance of common stock
    381,000 367,000 616,000 1,305,000 4,293,000 312,000 1,190,000 3,610,000 805,000 214,000 165,000 742,000 1,259,000 222,000 763,000 1,615,000 242,000 2,638,000 6,059,000 3,137,000 132,000 688,000 440,000 649,000 843,000 2,390,000 2,191,000 418,000 1,483,000 754,000 1,636,000 1,800,000 1,197,000 2,311,000 200,000 23,000 2,000 5,000 -1,000 5,000 27,000 18,000 165,000 244,000 148,000 87,000 17,000 68,000 212,000 -101,000 76,773,000 
      repurchase of common stock
    -10,601,000 -17,087,000 -4,490,000         -31,000 -18,567,000 -8,056,000 -6,190,000 -5,602,000           -6,505,000 -3,495,000 5,099,000 -997,000   -3,200,000 -800,000               
      payment of excise tax associated with repurchase of common stock
    -171,000                                                     
      net cash from financing activities
    -10,391,000 -17,152,000 -3,874,000 -49,079,000 4,293,000 312,000 1,190,000 3,610,000 805,000 214,000 165,000 742,000 1,228,000 -18,345,000 -7,293,000 -4,575,000 -5,360,000 -8,916,000 6,059,000 3,137,000 132,000 687,000 418,000 628,000 816,000 2,362,000 2,157,000 364,000 1,441,000 -5,793,000 -1,898,000 6,625,000 198,000 -6,058,000 186,000 41,000 -32,000 -3,255,000 -867,000 -55,000 -60,000 -23,000 -129,000 69,000 -84,000 161,000 -25,000 -1,362,000 -24,000 109,000 212,000 -133,000 76,762,000 
      effect of exchange rate differences on cash and cash equivalents
    -2,000 27,000 33,000 -29,000 1,000 -5,000 -19,000 6,000 -14,000 33,000 8,000     -28,000 -20,000 5,000 -25,000 15,000 26,000 10,000 -25,000    -4,000 -22,000 -8,000 36,000 -14,000 9,000 24,000 -78,000 -12,000 3,000 26,000 -9,000 -3,000 -12,000 -8,000   -18,000 -2,000 -16,000 -15,000 -15,000   -16,000 -13,000 -13,000 
      net change in cash, cash equivalents and restricted cash
    -10,078,000 7,913,000 19,511,000 -33,636,000 22,950,000 -30,464,000 2,682,000 16,659,000 7,201,000 -22,090,000 9,997,000 4,223,000 8,908,000 -1,296,000 -29,838,000 8,613,000 -37,557,000 -2,129,000 11,176,000 14,106,000 17,180,000 30,129,000 6,455,000 -3,309,000 6,378,000 6,244,000 -4,963,000  16,717,000 -16,171,000 2,817,000                       
      cash, cash equivalents and restricted cash, beginning of year
    29,757,000 68,225,000 56,458,000 74,461,000 94,358,000 26,488,000 22,138,000  30,626,000                       
      cash, cash equivalents and restricted cash, end of period
    -10,078,000 7,913,000 49,268,000  22,950,000 -30,464,000 70,907,000  7,201,000 -22,090,000 66,455,000  8,908,000 -1,296,000 44,623,000  -37,557,000 -2,129,000 105,534,000  17,180,000 30,129,000 32,943,000  6,378,000 6,244,000 17,175,000  16,717,000 -16,171,000 33,443,000                       
      sales of marketable securities
                     806,000 4,793,000 4,974,000 4,073,000                              
      cash, cash equivalents and restricted cash, end of year
                                                         
      supplemental disclosure of cash flow information:
                                                         
      cash received for income tax refunds
                                                         
      cash paid for income taxes
                                               -811,000 20,000 625,000 1,001,000 44,000 105,000 281,000 3,159,000 438,000 2,103,000 
      supplemental disclosure on non-cash investing and financing transactions:
                                                         
      purchases of property and equipment in trade accounts payable, and accrued expenses and other liabilities
                                                         
      excise tax on share repurchases, accrued but not paid
                                                         
      amortization of premiums and discounts on investments
           -249,000 -230,000 -294,000 -89,000 33,000 140,000 219,000 288,000 230,000 201,000 68,000 71,000     102,000 -7,000                             
      right of use asset depreciation
            415,000 406,000 402,000                                           
      capital expenditures and proceeds from sales of fixed assets
             -570,000 -197,000                                           
      rou asset depreciation
                                                         
      tax payment for employee shares withheld
                       -1,000 -22,000 -21,000 -27,000 -28,000 -34,000 -35,000 -39,000 -39,000 -37,000                       
      non-cash lease liabilities arising from obtaining right of use assets
                                                         
      effect of exchange rate differences on cash, cash equivalents and restricted cash
                34,000 15,000 -11,000                                       
      other
                                                  1,000    -4,000 
      proceeds from sale of assets
                      5,000                                   
      benefit from warranty claims
                       87,000 143,000 75,000 98,000 63,000 97,000 90,000 152,000 113,000 78,000 87,000 48,000 112,000 38,000 -1,000 97,000 318,000 109,000 203,000 -29,000 120,000 216,000 176,000 77,000 399,000 120,000 206,000 121,000    28,000 36,000 19,000 
      income taxes
                       7,000 -21,000 3,000 -3,000 -17,000 37,000 10,000  -61,000                         
      repayment of long-term debt
                               -19,000 -3,000 -3,000 -2,000 -4,000 -2,000   -21,000 -32,000 -32,000 -32,000 -32,000 -32,000 -32,000 -32,000 -32,000 -32,000 -202,000 -1,711,000 -32,000 -32,000 -120,000 -43,000 -43,000 
      cash paid for interest
                                               21,000 15,000 16,000 21,000 15,000 10,000 10,000 14,000 15,000 15,000 
      amortization (accretion) of premiums and discounts on investments
                        96,000 -5,000 220,000                               
      foreign currency transactions
                                                         
      realized gain on sale of investments
                           -5,000                              
      reversal of accruals related to expired warranties
                           -62,000 -48,000 -36,000 -47,000 -9,000 -87,000 -34,000 -50,000 1,000 -55,000                     
      change in allowance for doubtful accounts
                                                         
      adjustments for excess or obsolete inventory
                           28,000 -69,000 24,000 38,000 65,000 115,000 13,000 4,000                       
      loss on disposal of fixed assets
                           12,000 50,000   350,000 36,000 1,000 21,000    13,000     30,000 -2,000 77,000           
      supplemental disclosure on non-cash transactions:
                                                         
      unrealized gain on foreign currency translation
                            30,000      113,000                       
      benefit from doubtful accounts
                            -20,000 35,000 -34,000 8,000 320,000 8,000 -13,000 52,000 -24,000 40,000         18,000 7,000 -133,000 -28,000 168,000 -267,000 256,000 4,000 1,000 5,000 
      contract assets, costs and estimated earnings in excess of billings
                            846,000                             
      contract liabilities, cost in excess of billings
                            -2,397,000                             
      adjustments to reconcile net income to net cash from operating activities:
                                                         
      amortization of premiums on investments
                              -26,000 -18,000 113,000 177,000 90,000 366,000 60,000                     
      unrealized (gain) loss on foreign currency translation
                              -56,000                           
      income taxes payable
                                  -3,000 281,000 46,000 85,000 4,000 6,000 3,000 2,000 8,000 -2,000 8,000 5,000 -55,000 -12,000 7,000 -275,000 184,000 -64,000 30,000 -1,463,000 1,131,000 85,000 
      net change in cash and cash equivalents and restricted cash
                                                         
      cash and cash equivalents and restricted cash, beginning of year
                                                         
      cash and cash equivalents and restricted cash, end of year
                                                         
      unrealized loss on foreign currency translation
                                                         
      unbilled receivables
                                   -2,194,000 890,000 -2,151,000 2,232,000 -3,469,000 -1,169,000 -354,000 162,000 1,062,000 1,981,000 789,000 -2,651,000 -413,000 1,576,000 2,694,000 -618,000 1,005,000 -1,553,000 1,785,000 93,000 -3,182,000 1,542,000 
      costs and estimated earnings in excess of billings
                                   -2,733,000                      
      litigation settlement
                                                         
      deferred revenue, product
                                   -1,062,000 -298,000                     
      deferred revenue, license and development
                                                         
      restricted cash
                                     -374,000 59,000 707,000 -1,035,000 2,211,000 -565,000 -293,000 -5,094,000 482,000 866,000 1,047,000 1,941,000 836,000 122,000 -5,300,000 219,000 3,299,000 -8,779,000 -265,000 
      proceeds from long-term debt
                                                         
      net change in cash and cash equivalents
                                   -14,344,000 1,704,000 -17,725,000 -3,219,000 -1,645,000 -542,000       -1,464,000 4,693,000 1,598,000 -8,604,000 -15,610,000 -4,906,000 4,627,000 -4,283,000 -534,000 78,166,000 
      cash and cash equivalents, beginning of year
                                                         
      cash and cash equivalents, end of year
                                                         
      supplemental disclosure of non-cash transactions:
                                                         
      purchases of property and equipment in trade accounts payable and accrued expenses and other liabilities
                                                         
      cash flows from operating activities
                                                         
      unrealized loss on foreign currency transactions
                                    13,000                     
      change in fair value of put options
                                                        
      valuation adjustments for excess or obsolete inventory
                                    -133,000 -22,000 -20,000 837,000 16,000 22,000 -18,000 303,000 12,000 -174,000 225,000 8,000 49,000 66,000 101,000       
      deferred revenue, slb license
                                    -1,250,000                     
      cash flows from investing activities
                                                         
      change in restricted cash
                                                         
      cash flows from financing activities
                                                         
      cash and cash equivalents, beginning of period
                                    83,289,000 16,642,000  18,507,000 55,338,000 59,115,000 79,287,000 
      cash and cash equivalents, end of period
                                    1,704,000 65,564,000 13,423,000  -542,000 3,067,000 15,762,000 -26,923,000 -4,966,000 -2,193,000 52,589,000 -1,464,000 4,693,000 1,598,000 50,511,000 -15,610,000 -4,906,000 4,627,000 75,004,000 -534,000 78,166,000 
      amortization of premiums/discounts on investments
                                      89,000  115,000                 
      interest accrued on notes receivables from stockholders
                                       -1,000   -1,000 -1,000 -2,000 -1,000 -1,000 -2,000 -3,000 -3,000 
      share-based compensation
                                      687,000 518,000 589,000 725,000 783,000 524,000 706,000 707,000 607,000 746,000 720,000         
      gain on foreign currency transactions
                                      10,000                 756,000 203,000 
      deferred revenue
                                      -334,000 -989,000 524,000 72,000 602,000 361,000 212,000 -358,000 -1,594,000 -1,518,000 -133,000 -1,389,000 910,000 -510,000 -1,094,000 -56,000 -1,301,000 2,165,000 107,000 
      purchase of marketable securities
                                      -3,464,000  -861,000               
      repayment of capital lease obligation
                                      -14,000 -6,000 -13,000 -23,000 -40,000 -22,000 -33,000 -34,000 -115,000 -109,000 -52,000 -56,000 -51,000 -10,000 -10,000 -8,000 -10,000 -9,000 -10,000 
      non-cash restructuring charges
                                                         
      impairment of intangible assets
                                                         
      loss on foreign currency transactions
                                       -8,000                  
      excess tax benefit from share-based compensation arrangements
                                           -7,000 2,000   15,000         
      benefit from (recovery of) doubtful accounts
                                                         
      amortization of inventory acquisition valuation step-up
                                               20,000 428,000 422,000       
      gain on fair value remeasurement
                                                         
      write-down of inventories
                                                         
      proceeds from sale of capitalized assets
                                           355,000 360,000 55,000           
      repayment of notes receivable from stockholders
                                                         
      supplemental disclosure of cash flow information
                                                         
      supplemental disclosure of non-cash transactions
                                                         
      loss on impairment of assets held for sale
                                        164,000                 
      (recovery of) benefit from doubtful accounts
                                                         
      adjustments to reconcile net (loss) to net cash from operating activities:
                                                         
      amortization (accretion) of premiums/discounts on investments
                                          154,000               
      net unrealized (gain) loss on foreign currency transactions
                                          -51,000   -40,000 -188,000           
      benefit from (recoveries of) doubtful accounts
                                          31,000               
      net decrease in cash and cash equivalents
                                          -2,745,000  -4,966,000 -2,193,000 -2,749,000           
      acquisition, net of cash acquired
                                                         
      issuance of common stock related to acquisition of a business
                                                         
      capitalization of construction in progress related to lease allowance
                                                         
      net unrealized loss on foreign currency transactions
                                                         
      provisions for (recoveries of) doubtful accounts
                                            -41,000             
      collection of notes receivables from stockholders
                                                         
      deferred tax assets and liabilities
                                                         
      repayment of notes receivables from stockholders
                                                -1,000 55,000  1,000 81,000 130,000  42,000 
      recoveries of doubtful accounts
                                              -10,000           
      issuance of common stock in exchange for notes receivable from stockholders
                                                       6,000 
      net unrealized gain on foreign currency transactions
                                                -60,000 82,000 14,000       
      deferred tax assets
                                                51,000 -1,000 143,000      
      net cash (used in) investing activities
                                                 -1,531,000 -4,077,000       
      excess tax benefit from stock-based compensation arrangements
                                                  -25,000       
      repayment of revolving note
                                                         
      other short term financing activities
                                                        
      benefit from (reversal of) warranty claims
                                                    18,000     
      benefit from excess or obsolete inventory
                                                    -27,000 12,000 74,000 -3,000 -24,000 
      net gain on foreign currency transactions
                                                     -129,000 -337,000   
      equipment purchased under capital leases
                                                         
      customer deposits
                                                        1,904,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.